Skip to main content
. 2022 Dec 31;15(1):139. doi: 10.3390/pharmaceutics15010139
NSCLC Non-small cell lung cancer
SCLC Small-cell lung carcinoma
DPIs Dry-powder inhalers
Dae Aerodynamic diameter
EPR Enhanced permeability and retention
PLGA Polylactic-co-glycolic
PEG Polyethylene glycol
CD-RES NP Resveratrol-cyclodextrin nanoparticles
SF Sorafenib
PLA Poly-L-arginine
DOX Doxorubicin
AQ Amodiaquine
HPH High-pressure homogenization
BSA Bovine serum albumin
PEI Polyethyleneimine
Cs Chitosan
F Fucoidan
HTCC N-[(2-hydroxy-3- trimethylammonium)propyl] chitosan chloride
SLNs Solid lipid nanoparticles
LPN Lipid–polymer hybrid nanoparticles
NLCs Nanostructured lipid carriers
SD Sprague–Dawley
PFD Pirfenidone
PTX Paclitaxel
DLPC Dilauroylphosphatidyl choline
CLH Hydroxycamptothecin
5-ALA 5-aminolevulinic acid
5-FU 5-Fluorouracil
DPPC Dipalmitoyl phosphatidylcholine
DPPG Dipalmitoyl phosphatidylglycerol
DPPA Dipalmitoyl phosphatidic acid
NEs Nanoemulsions
PDI Polydispersity index
LDH Lactate dehydrogenase
CU Curcumin
DOTAP (N-[1-(2,3-dioleoyloxy)propyl]-N,N,N-trimethylammonium) or 1, 2-dioleoyl-3-trimethylammonium propane
LPHNs Lipid–polymer hybrid nanoparticles
DLPC Dilauroylphosphatidylcholine
9NC 9-Nitrocamptothecin
GPs Gelatin nanoparticles
MNPs Magnetic nanoparticles
MSNs Mesoporous silica NPs
ZnO-NPs Zinc oxide nanoparticles
Cp Cisplatin
Sb-GNPs Gemcitabine (Gem) silibinin-loaded gold nanoparticles
CMC Critical micellar concentration
DTX Docetaxel
pMDIs Pressurized metered-dose inhalers